Kindred Biosciences financials at a glance
| Year | Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2012 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $1.97M | $4.26M | $3.46M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 83.52% | 86.21% | -33.55% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | $0.00 | |||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
16.17m | 19.71m | 19.81m | 19.89m | 28.16m | 33.91m | 39.09m | 39.45m | 45.27m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-1.57M | $-21.93M | $-22.76M | $-18.78M | $-21.88M | $-45.04M | $-56.34M | $-9.86M | $0.00M | $-0.25M | $0.00M |
| FCF | Free Cash Flow |
|
$-1.59M | $-22.37M | $-23.49M | $-19.73M | $-27.80M | $-58.95M | $-64.77M | $-13.50M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.43 | $-1.19 | $-1.19 | $-0.99 | $-1.11 | $-1.90 | $-1.68 | $-0.34 | $0.00 | $-0.12 | $0.00 |